Completed PHASE4 INTERVENTIONAL NCT00367081

Treatment of Cerebral Toxoplasmosis in HIV/AIDS

Pyrimethamine Plus Sulfadiazine Versus Trimethoprim Plus Sulfamethoxazole for Treatment of Toxoplasmic Encephalitis in AIDS Patients: A Randomized Controlled Trial.

Sponsor: Chiang Mai University

Conditions AIDS Toxoplasmic Encephalitis

Interventions Pyrimethamine plus Sulfadiazine plus leucoverin TMX-SMX (Bactrim(R))

Updated 6 times since 2017 Last updated: Jul 29, 2007 Started: May 31, 2003 Completion: Aug 31, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on AIDS and Toxoplasmic Encephalitis, this trial is completed. The trial is conducted by Chiang Mai University and has accumulated 6 data snapshots since 2003. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

May 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — May 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

May 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chiang Mai University
Department of Medical Services Ministry of Public Health of Thailand

Data source: Department of Medical Services Ministry of Public Health of Thailand

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chiang Mai, Thailand